Big Cypress Acquisition Corp. Unit
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch BCYPU and buy or sell other stocks, ETFs, and their options commission-free!About BCYPU
SAB Biotherapeutics, Inc. is a clinical-stage, biopharmaceutical company, which engages in advancing a new class of immunotherapies leveraging fully-human polyclonal antibodies. The firm produces human polyclonal immunotherapies and its versatile DiversitAb platform is applicable for unmet needs in human diseases.
CEOSamuel J. Reich
CEOSamuel J. Reich
Employees63
Employees63
HeadquartersMiami Beach, Florida
HeadquartersMiami Beach, Florida
Founded2014
Founded2014
Employees63
Employees63
BCYPU Key Statistics
Market cap407.02M
Market cap407.02M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume5.66K
Average volume5.66K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$14.69
52 Week high$14.69
52 Week low$8.57
52 Week low$8.57
Stock Snapshot
The current Big Cypress Acquisition Corp. Unit(BCYPU) stock price is $8.57, with a market capitalization of 407.02M.
Big Cypress Acquisition Corp. Unit(BCYPU) stock opened on 2025-12-09 at —. The price climbed to — and dipped to —.
Big Cypress Acquisition Corp. Unit(BCYPU) shares are trading with a volume of 0, against a daily average of 5.66K.
In the last year, Big Cypress Acquisition Corp. Unit(BCYPU) shares hit a 52-week high of $14.69 and a 52-week low of $8.57.
In the last year, Big Cypress Acquisition Corp. Unit(BCYPU) shares hit a 52-week high of $14.69 and a 52-week low of $8.57.